Gibbon ape leukemia virus poorly replicates in primary human T lymphocytes: Implications for safety testing of primary human T lymphocytes transduced with GALV-pseudotyped vectors

Journal of Immunotherapy

Volumn 32, Issue 3, 2009, Pages 272-279

  Lamers, Cor H J ^a   Willemsen, Ralph A ^a   Van Elzakker, Pascal M M L ^a   Gratama, Jan Willem ^a   Debets, Reno ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Gibbon ape leukemia virus; Human T lymphocytes; Immunogene therapy; Replication competent retrovirus; Safety testing

Indexed keywords

CARBONATE DEHYDRATASE IX; CARBONATE DEHYDRATASE IX ANTIBODY; RETROVIRUS VECTOR; SINGLE CHAIN FRAGMENT VARIABLE ANTIBODY; UNCLASSIFIED DRUG;

ARTICLE; CELL EXPANSION; CELL STRAIN HEK293; CONTROLLED STUDY; GENE AMPLIFICATION; GIBBON LEUKEMIA VIRUS; HUMAN; HUMAN CELL; LYMPHOCYTE CULTURE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; VIRUS REPLICATION; ANIMAL; BIOASSAY; GENE VECTOR; GENETIC TRANSDUCTION; GENETICS; PHYSIOLOGY; SENSITIVITY AND SPECIFICITY; VIROLOGY;

ANIMALS; BIOLOGICAL ASSAY; GENETIC VECTORS; HUMANS; LEUKEMIA VIRUS, GIBBON APE; SENSITIVITY AND SPECIFICITY; T-LYMPHOCYTES; TRANSDUCTION, GENETIC; VIRUS REPLICATION;

EID: 67449085171     PISSN: 15249557     EISSN: None     Source Type: Journal    
DOI: 10.1097/CJI.0b013e318199840a     Document Type: Article

References (28)

1. Miller AD, Garcia JV, von Suhr N, et al. Construction and properties of retrovirus packaging cells based on gibbon ape leukemia virus. J Virol. 1991;65:2220-2224.
2. Bauer TR Jr, Miller AD, Hickstein DD. Improved transfer of the leukocyte integrin CD18 subunit into hematopoietic cell lines by using retroviral vectors having gibbon ape leukemia virus envelope. Blood. 1995;86:2379-2387.
3. Bunnell BA, Muul LM, Donahue RE, et al. High-efficiency retroviral-mediated gene transfer into human and non-human primate peripheral blood lymphocytes. Proc Natl Acad Sci USA. 1995;92:7739-7743.
4. Weijtens MEM, Willemsen RA, Valerio D, et al. Single chain Ig/g gene-redirected human T lymphocytes produce cytokines, specifically lyse tumor cells, and recycle lytic capacity. J Immunol. 1996;157:836-843.
5. Chen J, Reeves L, Cornetta K. Safety testing for replication-competent retrovirus associated with gibbon ape leukemia virus-pseudotyped retroviral vectors. Hum Gene Ther. 2001;12: 61-70.
6. Lamers CHJ, Willemsen RA, Luider BA, et al. Protocol for gene transduction and expansion of human T lymphocytes for clinical immunogene therapy of cancer. Cancer Gene Ther. 2002;9:613-623.
7. Huges MS, Yu YYL, Dudley ME, et al. Transfer of a TCR gene derived from a patient with a marked antitumor response conveys highly active T-cell effector functions. Hum Gene Ther. 2005;16:457-472.
8. Heemskerk B, Liu K, Dudely ME, et al. Adoptive transfer for patients with melanoma, using tumor-infiltrating lymphocytes genetically engineered to secrete interleukin-2. Hum Gene Ther. 2008;19:496-510.
9. Donahue RE, Kessler SW, Bodine D, et al. Helper virus induced T cell lymphoma in non human primates after retroviral mediated gene transfer. J Exp Med. 1992; 176: 1125-1135.
10. Wilson CA, Ng TH, Miller AE. Evaluation of recommendations for replication-competent retrovirus testing associated with use of retroviral vectors. Hum Gene Ther. 1997;8:869-874.
11. Guidance for industry. Supplemental guidance on testing for replication competent retrovirus in retroviral vector based gene therapy products and during follow-up of patients in clinical trials using retroviral vectors. November 2006 (http:/www.fda.gov/cber/guidelines.htm).
12. Cornetta K, Nguyen N, Morgan RA, et al. Infection of human cells with murine amphotropic replication-competent retroviruses. Hum Gene Ther. 1993;4:579-588.
13. Forestell SP, Dando JS, Bohnlein E, et al. Improved detection of replication-competent retrovirus. J Virol Methods. 1996;60: 171-178.
14. Martineau D, Klump WM, McCormack JE, et al. Evaluation of PCR and ELISA assays for screening clinical trial subjects for replication-competent retrovirus. Hum Gene Ther. 1997;8: 1231-1241.
15. Chen J, Reeves L, Sanburn N, et al. Packaging cell line DNA contamination of vector supernatants: implications for laboratory and clinical research. Virology. 2001;282:186-197.
16. Bassin RH, Ruscetti S, Ali L, et al. Normal DBA/2 mouse cells synthesize a glycoprotein which interferes with MCF virus infection. Virology. 1982;123:139-151.
17. Ebeling SB, Simonetti ER, Borst HP, et al. Human primary T lymphocytes have a low capacity to amplify MLV-based amphotropic RCR and the virions produced are largely noninfectious. Gene Ther. 2003;10:1800-1806.
18. Kawakami TG, Huff SD, Buckley PM, et al. C-type virus associated with gibbon lymphosarcoma. Nat New Biol. 1972; 235:170-171.
19. Haapala DK, Robey WG, Oroszlan SD, et al. Isolation from cats of an endogenous type C virus with novel envelope glycoprotein. J Virol. 1985;53:827-833.
20. Lamers CHJ, van de Griend RJ, Braakman E, et al. Optimization of culture conditions for activation and large-scale expansion of human T lymphocytes for bi-specific antibody-directed cellular immunotherapy. Int J Cancer. 1992; 51:973-979.
21. Weijtens ME, Willemsen RA, Hart E, et al. A retroviral vector system "Stitch" in combination with an optimized single chain antibody chimeric receptor gene structure allows efficient transduction and expression in human T lymphocytes. Gene Ther. 1998;5:1195-1203.
22. Van de Griend RJ, van Krimpen BA, Bol SJ, et al. Rapid expansion of human T cell clones: growth promotion by a heat-labile serum component and by various types of feeder cells. J Immunol Methods. 1984;66:285-298.
23. Kawakami TG, Kollias GV, Holmberg C. Oncogeneticity of gibbon type-C myelogenous leukemia virus. Int J Cancer. 1980;25:641-646.
24. Holbrook NJ, Gulino A, Ruscetti F. Cis-acting transcriptional regulatory sequences in the gibbon ape leukemia virus (GALV) long terminal repeat. Virology. 1987;157:211-219.
25. Wilson CA, Farrel KB, Eiden MV. Comparison of cDNAs encoding the gibbon ape leukemia virus receptor from susceptible and non-susceptible murine cells. J Gen Virol. 1994; 75:1901-1908.
26. Ting YT, Wilson CA, Farrell KB, et al. Simian sarcoma-associated virus fails to infect Chinese hamster cells despite the presence of functional gibbon ape leukemia virus receptors. J Virol. 1998;72:9453-9458.
27. Overbaugh J, Miller AD, Eiden MV. Receptors and entry cofactors for retroviruses include single and multiple trans-membrane-spanning proteins as well as newly described glycophosphatidylinositol-anchored and secreted proteins. Microbiol Mol Biol Rev. 2001;65:371-389.
28. Ebeling SB, Simonetti E, Laufs S, et al. Human T cells efficiently abort RCR-infection through a CEM15/APOBEC3G-mediated mechanism. Mol Ther. 2004;9:S125.